Aker ASA (AKER):企業の財務・戦略的SWOT分析

◆英語タイトル:Aker ASA (AKER) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C2988
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:75
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ノルウェー
◆産業分野:サービス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Aker ASA (AKER) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aker ASA (Aker) is an industrial investment company that operates through Industrial Holdings and Financial Investments. It invests mainly in energy, environment, fisheries and marine biotech, and finance. Its Industrial Holdings include Aker Solutions ASA, Aker BP, Akastor ASA, Ocean Yield AS, Aker BioMarine ASA and Kvaerner ASA. The company’s Financial Investments comprise Philly Shipyard and Solstad Offshore. Aker promotes operational improvements, sector structural rationalization, optimal financing, mergers, acquisitions, and sales of business. It also invests in specialized funds managed by various management companies. Aker is headquartered in Lysaker, Norway.

Aker ASA Key Recent Developments

Jul 18,2018: Aker announces second-quarter and half-year results 2018 – Net Asset Value of NOK 57.1 billion
May 09,2018: Aker Announces First-Quarter Results 2018 – Net Asset Value Of NOK 42.4 Billion
Feb 20,2018: Maersk Energy Sees Uptick In Offshore Oil Drilling, Profit Still Squeezed
Feb 16,2018: Aker Announces Fourth-quarter And Preliminary Annual Results 2017 – Net Asset Value Up By 20.4 Percent To NOK 41.8 Billion – Cash Dividend Of NOK 18 Per Share Proposed
Dec 11,2017: Aker Announces Kristian Rokke Appointed As Chief Investment Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Aker ASA – Key Facts 6
Aker ASA – Key Employees 7
Aker ASA – Key Employee Biographies 8
Aker ASA – Major Products and Services 9
Aker ASA – History 10
Aker ASA – Company Statement 12
Aker ASA – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Affiliate 18
Section 2 – Company Analysis 19
Company Overview 19
Aker ASA – Business Description 20
Business Segment: Financial Investments 20
Overview 20
Performance 20
Key Stats 20
Business Segment: Industrial Holdings 20
Overview 20
Performance 21
Key Stats 21
Geographical Segment: Asia 21
Performance 21
Geographical Segment: European Union 21
Performance 21
Geographical Segment: Norway 21
Performance 21
Geographical Segment: Others 21
Performance 21
Geographical Segment: The Americas 21
Performance 21
Aker ASA – SWOT Analysis 22
SWOT Analysis – Overview 22
Aker ASA – Strengths 22
Aker ASA – Weaknesses 23
Aker ASA – Opportunities 24
Aker ASA – Threats 25
Aker ASA – Key Competitors 26
Section 3 – Company Financial Ratios 27
Financial Ratios – Capital Market Ratios 27
Financial Ratios – Annual Ratios 28
Performance Chart 31
Financial Performance 31
Financial Ratios – Interim Ratios 32
Financial Ratios – Ratio Charts 33
Aker ASA, Recent Deals Summary 34
Section 4 – Company’s Recent Developments 35
Jul 18, 2018: Aker announces second-quarter and half-year results 2018 – Net Asset Value of NOK 57.1 billion 35
May 09, 2018: Aker Announces First-Quarter Results 2018 – Net Asset Value Of NOK 42.4 Billion 36
Feb 16, 2018: Aker Announces Fourth-quarter And Preliminary Annual Results 2017 – Net Asset Value Up By 20.4 Percent To NOK 41.8 Billion – Cash Dividend Of NOK 18 Per Share Proposed 42
Dec 11, 2017: Aker Announces Kristian Rokke Appointed As Chief Investment Officer 50
Jul 18, 2017: Aker Announces Second-Quarter And Half-Year Results 2017 51
May 11, 2017: Aker Announces First-Quarter Results 2017 57
Feb 28, 2017: Aker Announces Fourth-quarter and preliminary annual results 2016 64
Section 5 – Appendix 71
Methodology 71
Ratio Definitions 71
About GlobalData 75
Contact Us 75
Disclaimer 75

List of Tables
Aker ASA, Key Facts 6
Aker ASA, Key Employees 7
Aker ASA, Key Employee Biographies 8
Aker ASA, Major Products and Services 9
Aker ASA, History 10
Aker ASA, Subsidiaries 16
Aker ASA, Affiliate 18
Aker ASA, Key Competitors 26
Aker ASA, Ratios based on current share price 27
Aker ASA, Annual Ratios 28
Aker ASA, Annual Ratios (Cont...1) 29
Aker ASA, Annual Ratios (Cont...2) 30
Aker ASA, Interim Ratios 32
Aker ASA, Recent Deals Summary 34
Currency Codes 71
Capital Market Ratios 71
Equity Ratios 72
Profitability Ratios 72
Cost Ratios 73
Liquidity Ratios 73
Leverage Ratios 74
Efficiency Ratios 74

List of Figures
Aker ASA, Performance Chart (2013 - 2017) 31
Aker ASA, Ratio Charts 33

★海外企業調査レポート[Aker ASA (AKER):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • 3SBio Inc (1530):製薬・医療:M&Aディール及び事業提携情報
    Summary 3SBio Inc (3SBio) is a biotechnology companies that carries out the research, development, manufacturing and marketing of biopharmaceutical products. It develops recombinant, or genetically engineered, protein-based products and other pharmaceutical product candidates to address large market …
  • Larsen & Toubro Infotech Ltd (LTI):企業の財務・戦略的SWOT分析
    Larsen & Toubro Infotech Ltd (LTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Alvogen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Alvogen Inc (Alvogen) is a pharmaceutical company that develops, manufactures and markets generic pharmaceuticals, brand and over the counter (OTC) products. The company offers generic medications in the therapeutic areas of oncology, cardiology, respiratory, neurology and gastroenterology. …
  • Bunzl plc (BNZL):企業の財務・戦略的SWOT分析
    Bunzl plc (BNZL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Baltimore Gas and Electric Company:発電所・企業SWOT分析
    Baltimore Gas and Electric Company - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information o …
  • Fanhua Inc:企業のM&A・事業提携・投資動向
    Fanhua Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fanhua Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • ZH International Holdings Ltd:企業の戦略・SWOT・財務情報
    ZH International Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary ZH International Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Accredo Health Group Inc:企業の戦略的SWOT分析
    Accredo Health Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • SLM Corp:企業の戦略・SWOT・財務情報
    SLM Corp - Strategy, SWOT and Corporate Finance Report Summary SLM Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Rexahn Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Rexahn Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rexahn Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Marathon Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Marathon Pharmaceuticals LLC (Marathon Pharmaceuticals) focuses on the development, manufacturing and commercialization of treatments for rare neurological and movement disorders. It develops products in various therapeutic areas which include duchenne muscular dystrophy, pediatric juvenile …
  • Sarku Japan:企業の戦略・SWOT・財務情報
    Sarku Japan - Strategy, SWOT and Corporate Finance Report Summary Sarku Japan - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Enstar Group Ltd.:企業の戦略・SWOT・財務情報
    Enstar Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary Enstar Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Hemanext:製薬・医療:M&Aディール及び事業提携情報
    Summary Hemanext, formerly New Health Sciences Inc, is a medical technology company that develops blood storage systems. The company offers an anaerobic storage system that minimizes oxidative damage to red blood cells in storage and delivers physiologic, therapeutic, and fresher red blood cell than …
  • Nidec Corporation:戦略・SWOT・企業財務分析
    Nidec Corporation - Strategy, SWOT and Corporate Finance Report Summary Nidec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Drexel University:製薬・医療:M&Aディール及び事業提携情報
    Summary Drexel University (Drexel) is a research university which provides educational degrees and research programs. The university offers courses for undergraduate courses, graduate and professional courses, adult education programs, colleges and schools, libraries and online training services. It …
  • Exact Sciences Corp (EXAS)-医療機器分野:企業M&A・提携分析
    Summary Exact Sciences Corp (Exact) is a molecular diagnostic company that focuses on the early detection and prevention of various cancers. The company’s flagship product, Cologuard test is a non-invasive stool-based deoxyribonucleic acid (DNA) screening product indicated for the early detection of …
  • Precision System Science Co Ltd (7707)-医療機器分野:企業M&A・提携分析
    Summary Precision System Science Co Ltd (PSS) is a medical device company that develops, manufactures and sells automated systems, physicochemical instruments, software, and others. The company’s products include automated nucleic acid isolation system, large sample volume nucleic acid extraction sy …
  • Tractebel Engineering:企業の戦略的SWOT分析
    Tractebel Engineering - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Mettler-Toledo International Inc:企業の戦略・SWOT・財務分析
    Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report Summary Mettler-Toledo International Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆